0001581178-23-000003.txt : 20230822
0001581178-23-000003.hdr.sgml : 20230822
20230822170347
ACCESSION NUMBER: 0001581178-23-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230822
DATE AS OF CHANGE: 20230822
EFFECTIVENESS DATE: 20230822
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: EUPRAXIA PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001581178
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-490433
FILM NUMBER: 231194425
BUSINESS ADDRESS:
STREET 1: 201-2067 CADBORO BAY RD.
CITY: VICTORIA
STATE: A1
ZIP: V8R 5G4
BUSINESS PHONE: 250-590-3968
MAIL ADDRESS:
STREET 1: 201-2067 CADBORO BAY RD.
CITY: VICTORIA
STATE: A1
ZIP: V8R 5G4
D
1
primary_doc.xml
X0708
D
LIVE
0001581178
EUPRAXIA PHARMACEUTICALS INC.
201-2067 CADBORO BAY RD.
VICTORIA
A1
BRITISH COLUMBIA, CANADA
V8R 5G4
250-590-3968
BRITISH COLUMBIA, CANADA
Plaza Capital Partners Inc.
None
Corporation
true
James
A
Helliwell
201 - 2067 Cadboro Bay Road
Victoria
A1
BRITISH COLUMBIA, CANADA
V8R 5G4
Executive Officer
Director
John
Montalbano
201 - 2067 Cadboro Bay Road
Victoria
A1
BRITISH COLUMBIA, CANADA
V8R 5G4
Director
Paul
Geyer
201 - 2067 Cadboro Bay Road
Victoria
A1
BRITISH COLUMBIA, CANADA
V8R 5G4
Director
Simon
Pimstone
201 -2067 Cadboro Bay Road
Victoria
A1
BRITISH COLUMBIA, CANADA
V8R 5G4
Director
Michael
Wilmink
201 - 2067 Cadboro Bay Road
Victoria
A1
BRITISH COLUMBIA, CANADA
V8R 5G4
Director
Richard
Glickman
201 - 2067 Cadboro Bay Road
Victoria
A1
BRITISH COLUMBIA, CANADA
V8R 5G4
Director
Amanda
Malone
201 - 2067 Cadboro Bay Road
Victoria
A1
BRITISH COLUMBIA, CANADA
V8R 5G4
Executive Officer
Bruce
Cousins
201 - 2067 Cadboro Bay Road
Victoria
A1
BRITISH COLUMBIA, CANADA
V8R 5G4
Executive Officer
President and CFO
Paul
Brennan
201 - 2067 Cadboro Bay Road
Victoria
A1
BRITISH COLUMBIA, CANADA
V8R 5G4
Executive Officer
Mark
Kowalski
201 - 2067 Cadboro Bay Road
Victoria
A1
BRITISH COLUMBIA, CANADA
V8R 5G4
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2023-08-18
false
true
false
0
Haywood Securities (USA) Inc.
42072
None
None
200 Burrard St
Suite 700
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 3L6
AZ
ARIZONA
false
128394
128394
0
The total offering amount, total amount sold, and total remaining to be sold reflect the conversion of Canadian dollar denominated figures to U.S. dollars at a rate of Cdn.$1.3552 = U.S. $1.00, the closing Bank of Canada exchange rate on August 18, 2023.
false
3
4339
0
0
false
EUPRAXIA PHARMACEUTICALS INC.
/s/ Bruce Cousins
Bruce Cousins
President and CFO
2023-08-18